Prescription Drug Transparency and Affordability Act

1. Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

   27 March 2025 · IntroReferral

2. Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

   27 March 2025 · IntroReferral

3. Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

   27 March 2025 · IntroReferral

4. Introduced in House

   27 March 2025 · IntroReferral

5. Introduced in House

   27 March 2025 · IntroReferral

Cosponsors

• Republican:Rep. Carter, Earl L. "Buddy" [R-GA-1]GA
• Democrat:Rep. Menendez, Robert [D-NJ-8]NJ
• Republican:Rep. James, John [R-MI-10]MI